mardi 26 mars 2019

Onco Actu du 26 mars 2019


1. BIOLOGIE



Mouse Study Yields Long-Awaited Insights into Human Stomach Cancer [Berkeley Lab]











Like racecars and geese, cancer cells draft their way to new tumor sites [Vanderbilt University]











1.2 BIOLOGIE - BIOBANQUES



UK Biobank to Make Whole-Genome Sequencing Data on 500K-Sample Repository Publicly Available [Genome Web]











5. TRAITEMENTS



Leukemia Relapse After Stem Cell Transplant Linked to Transcriptional Signature [Genome Web]











A Clever New Strategy for Treating Cancer, Thanks to Darwin [Wired]










5.10 TRAITEMENTS - ESSAIS



New report: 25 major U.S. medical universities violate key transparency law [TranspariMed]











5.2 PHARMA



Nanobiotix announces its clinical registration plan in Head and Neck cancers for the United States following FDA feedback [Nanobiotix]











PharmaMar announces positive results in its lurbinectedin monotherapy trial for small cell lung cancer [PharmaMar]











After ovarian cancer flop, PharmaMar’s lurbinectedin makes the cut in small cell lung cancer [EndPoints]











5.4 TRAITEMENTS - ECONOMIE



NICE Issues Technology Appraisal Guidance for Brigatinib [ESMO]











5.9.9 AACR - IMMUNOTHÉRAPIES



Study may explain why immunotherapy not effective for some patients with metastatic melanoma and kidney cancer [MD Anderson Cancer Center]











6.1 OBSERVATION



GPs fuelling Britain's poor cancer survival rates by failing to refer patients to specialists, Imperial study finds [The Telegraph]










6.11 PATIENTS



My Friend’s Cancer Taught Me About a Hole in Our Health System [NY Times]










6.2 IMPLANTS MAMMAIRES



‘I was not warned’ - Women who say they were sickened by breast implants demand FDA action [Washington Post]











Women at Breast Implant Hearing Call for Disclosure of Safety Risks [NY Times]










6.5 MÉDECINES ALTERNATIVES/COMPLÉMENTAIRES



OncANP writes a “statement of principles” for naturopathic oncology quackery [Respectful Insolence]











6.7.1 IA/BIOINFORMATIQUE



A doctor’s hopes for digital medicine [The Economist]











6.9 CONTROVERSES



Retiring statistical significance would give bias a free pass [Nature]











The joy of stats [Nature]